Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline
N. Lynn Henry(University of Utah), Vered Stearns(Johns Hopkins University), Diana T. Chingos(Young Survival Coalition), Patricia A. Spears(University of North Carolina at Chapel Hill), Praveen Vikas(University of Iowa), Mark R. Somerfield(American Society of Clinical Oncology), Bruno Lemos Ferrari, Andrea Eisen(Sunnybrook Health Science Centre), Vandana G. Abramson(Vanderbilt University), Nofisat Ismaila(American Society of Clinical Oncology), Thomas H. Openshaw(Cape Cod Hospital), Kimberly H. Allison(Stanford University), Carey K. Anders(Duke University)
Cited by 87
Related Papers
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k